Syndax Pharmaceuticals, Inc. (SNDX)
20.11
+0.82
(+4.25%)
USD |
NASDAQ |
Sep 01, 16:00
20.11
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Net Income (TTM) : -220.76M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -220.76M |
| March 31, 2026 | -243.25M |
| December 31, 2025 | -285.42M |
| September 30, 2025 | -311.58M |
| June 30, 2025 | -334.99M |
| March 31, 2025 | -331.20M |
| December 31, 2024 | -318.76M |
| September 30, 2024 | -297.06M |
| June 30, 2024 | -264.08M |
| March 31, 2024 | -240.63M |
| December 31, 2023 | -209.36M |
| September 30, 2023 | -176.08M |
| June 30, 2023 | -160.34M |
| March 31, 2023 | -153.30M |
| December 31, 2022 | -149.34M |
| September 30, 2022 | -13.95M |
| June 30, 2022 | 0.818M |
| March 31, 2022 | 15.48M |
| December 31, 2021 | 24.93M |
| September 30, 2021 | -91.70M |
| Date | Value |
|---|---|
| June 30, 2021 | -91.49M |
| March 31, 2021 | -85.64M |
| December 31, 2020 | -77.06M |
| September 30, 2020 | -70.64M |
| June 30, 2020 | -63.03M |
| March 31, 2020 | -60.89M |
| December 31, 2019 | -56.05M |
| September 30, 2019 | -60.88M |
| June 30, 2019 | -65.39M |
| March 31, 2019 | -68.86M |
| December 31, 2018 | -73.96M |
| September 30, 2018 | -74.23M |
| June 30, 2018 | -71.98M |
| March 31, 2018 | -67.23M |
| December 31, 2017 | -60.80M |
| September 30, 2017 | -52.51M |
| June 30, 2017 | -52.39M |
| March 31, 2017 | -47.11M |
| December 31, 2016 | -44.47M |
| September 30, 2016 | -44.52M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Viking Therapeutics, Inc. | -534.80M |
| Kura Oncology, Inc. | -296.78M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |